Semaglutide Weight Loss Results: What to Expect

Last reviewed: June 3, 2026

Last updated: June 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes, has become one of the most studied medications for chronic weight management. Large-scale clinical trials show that patients using semaglutide lose substantially more weight than those on diet and exercise alone—but the exact amount varies based on individual biology, commitment to lifestyle changes, and how your body responds to the medication.

Clinical Trial Data on Semaglutide Weight Loss

The STEP trials, which tested semaglutide for weight management in non-diabetic adults, reported that participants lost an average of 10.2 kg (22.5 pounds) after 16 weeks at the 0.5 mg dose level. At higher therapeutic doses, participants achieved reductions of 15 to 22 percent of their starting body weight by week 68—meaning a 200-pound person could lose 30 to 44 pounds. These results far exceed what most patients achieve through diet and exercise modifications alone.

Weight loss typically follows a pattern: most participants experience notable changes in the first 4 to 8 weeks, with continued gradual losses through month 6. The majority of weight loss occurs during the first 20 weeks of treatment, after which losses tend to stabilize or slow. Importantly, participants who stopped taking semaglutide in follow-up studies regained a significant portion of the lost weight within one year, suggesting that maintaining results requires ongoing treatment.

Why Individual Weight Loss Results Vary Significantly

Two patients on identical semaglutide doses may experience different weight loss outcomes because genetics, metabolism, and appetite regulation vary from person to person. Your starting weight, age, insulin sensitivity, and baseline metabolic rate all influence how much weight you'll lose. Additionally, adherence to recommended dietary patterns and physical activity levels determine whether you achieve results at the lower or higher end of the expected range.

PlexusDx offers the Precision Peptide Genetic Test to identify how your body responds to GLP-1 therapy at the genetic level. The test examines key variants in pathways like GLP1R (rs6923761), GIPR (rs1800437), and MC4R (rs17782313) that affect appetite signaling and weight regulation. Understanding your genetic predisposition helps PlexusDx providers tailor your treatment approach and set realistic expectations for your specific results.

Realistic Weight Loss Timeline and Expectations

Most patients notice appetite reduction within the first 2 to 3 days of starting semaglutide, though measurable weight loss typically appears after 1 to 2 weeks of consistent use. By the end of month 1, many people lose 2 to 5 pounds as appetite suppression becomes established and calorie intake naturally decreases. Months 2 through 6 usually bring the most significant losses, with many patients losing 1 to 2 pounds per week during this window.

After six months, weight loss often plateaus as your body adapts to the medication and the benefits of calorie restriction reach an equilibrium. This is normal and expected—it reflects your body reaching a new, lower weight set-point under GLP-1 therapy. Continuing treatment at your maintenance dose typically preserves your weight loss rather than producing ongoing rapid losses.

How PlexusDx Semaglutide Therapy Supports Your Weight Loss

PlexusDx provides compounded semaglutide injections through licensed 503A compounding pharmacies, offering a personalized approach to GLP-1 therapy without requiring membership fees or insurance. Your dose can be adjusted based on your individual response and tolerance, and your price remains flat at the treatment tier you select—starting at $149 per month. This transparent pricing structure removes the surprise cost increases some patients experience elsewhere as doses are titrated upward.

PlexusDx also offers the Precision Peptide Genetic Test ($99 add-on after your first month of treatment) to map your specific peptide pathways across 14 biological systems and 49 peptides. This genetic insight helps your provider understand whether you're a responder likely to achieve weight loss in the 15-22 percent range, or whether a different GLP-1 compound or combination approach might suit your genetics better. HSA and FSA funds are eligible for both the medication and genetic testing.

Maintaining Weight Loss After Reaching Your Goal

Weight loss achieved on semaglutide is not permanent once you stop the medication—most people regain much of the lost weight within 12 months after discontinuation. This occurs because semaglutide works by reducing appetite and improving metabolic hormone signals; when treatment ends, those signals revert to their baseline state. For sustained results, long-term maintenance therapy at a lower holding dose is typically necessary.

Many patients and providers view semaglutide as a chronic management tool similar to how blood pressure medications maintain cardiovascular health long-term. Continuing your treatment at the dose that maintains your weight loss, combined with sustainable eating and activity habits, provides the best chance of preventing weight regain. Your PlexusDx provider can help you transition from a titration phase to a maintenance phase that balances effectiveness with comfort and cost.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Can I lose 50 pounds on semaglutide?

Yes, patients at higher starting weights often lose 50+ pounds when clinical trial data is extrapolated. A person beginning at 250 pounds losing 20 percent of body weight would lose 50 pounds. Individual results vary widely based on genetics, starting weight, dose, and lifestyle adherence. PlexusDx providers review your baseline metrics and heal...

How fast will I lose weight on semaglutide?

Most people experience noticeable appetite reduction within days and measurable weight loss within 1-2 weeks. The fastest losses typically occur months 2-6, with many patients losing 1-2 pounds weekly during this period. After six months, losses often slow as your body reaches metabolic equilibrium at the lower weight.

Is compounded semaglutide from PlexusDx as effective as brand-name Ozempic?

Compounded semaglutide contains the identical active pharmaceutical ingredient as Ozempic and is manufactured in licensed 503A compounding pharmacies meeting FDA sterility and potency standards. The mechanism and weight loss results are the same; the difference is access and cost. PlexusDx semaglutide starts at $149 per month with no insurance r...

What happens if I stop taking semaglutide?

Most people regain a significant portion of lost weight within 12 months after stopping semaglutide because appetite hormones and metabolic signals return to baseline. This is why weight loss achieved on GLP-1 therapy typically requires ongoing maintenance treatment. Your PlexusDx provider can discuss long-term treatment plans and transition opt...

How does the Precision Peptide Genetic Test predict my weight loss?

PlexusDx Precision Peptide Genetic Test examines variants in GLP1R, GIPR, FTO, and MC4R genes that influence appetite regulation, satiety signaling, and metabolic rate. These insights help identify whether you're genetically predisposed to respond strongly to semaglutide or whether a dual-compound approach like GLP-Squared might produce better r...

How Much Weight Can I Lose Using Ozempic?